MedTrace Logo

Assertiveness Training for Communication Skills

NCT07575048 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-08

No results posted yet for this study

Summary

This study aims to determine the effect of virtual reality-based assertiveness training on strengthening the communication skills of oncology nurses.

Conditions

  • Communication

Interventions

OTHER

Assertiveness Skills Training

The content of the Assertiveness Training is based on the assertiveness training developed by Michel and Fursland (2008). Session 1: Introduction, Welcome and Orientation, The Concept of Assertiveness; Session 2: Types of Behavior; Session 3: Assertiveness Techniques; Session 4: Dealing with Criticism; Session 5: Saying "No"; Session 6: Disappointment; Session 7: Relaxation Exercises; Session 8: Application, General Discussions and Evaluation. First, scenario-based videos will be created to develop assertiveness training skills, and these videos will be integrated into virtual reality glasses. Two videos will be created for each scenario. The first video will address a communication problem experienced by the nurse. The second video will be educational content using effective communication skills in the problem experienced by the nurse. Virtual reality applications will be conducted individually with each nurse.

Sponsors & Collaborators

  • Amasya University

    lead OTHER

Principal Investigators

  • Neşe Uysal · Amasya University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-30
Primary Completion
2026-11-15
Completion
2026-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07575048 on ClinicalTrials.gov